文献速递类风湿关节炎

类风湿关节炎与骨关节炎患者骨质疏松治疗与筛查趋势及影响因素

Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-03-11

该研究随访2003至2014年类风湿关节炎(RA)与骨关节炎(OA)患者,评估骨质疏松(OP)治疗或筛查(OPTS)的接受情况。中位随访5.5年间,67.4%的RA患者和64.6%的OA患者报告了OPTS;在2010年ACR糖皮质激素诱导性骨质疏松(GIOP)指南推荐治疗的患者中,约55%报告使用OP药物。RA患者接受OPTS的可能性并不高于OA患者(HR 1.04,95%CI 0.94-1.15),且2008年后两类患者的OPTS均呈显著下降趋势。

要点

  • RA患者OP筛查/治疗率不优于OA,2008年后两者均显著下降。
  • 2010年ACR GIOP指南推荐治疗者中约55%报告使用OP药物,近半数未用药。
  • RA中与OP care相关的因素包括高龄、绝经后、既往脆性骨折或OP诊断、任何疗程糖皮质激素及生物制剂使用。

核心结论

  • 约半数有治疗指征的RA患者从未接受OP药物治疗;RA的OP care不优于OA,且2008年后相对风险持续下降,2010年ACR GIOP指南发布后未见改善。

研究设计与样本

  • 回顾性随访研究,纳入2003至2014年随访的RA患者11,669例和OA患者2,829例,中位随访5.5年(IQR 2-9),采用多变量Cox比例风险模型分析调整后趋势及与OP care相关的因素。

主要发现

  • OPTS在67.4%的RA患者和64.6%的OA患者中报告;RA患者接受OPTS的可能性不高于OA患者(HR 1.04,95%CI 0.94-1.15)。
  • 与2003年相比,2004至2008年OPTS趋势稳定,2008年后RA和OA患者均呈显著下降趋势。
  • RA中与OP care相关的因素为高龄、绝经后状态、既往脆性骨折或OP诊断、任何疗程糖皮质激素治疗及生物制剂使用。

关键数值与推荐

  • 2010年ACR GIOP指南推荐治疗者占RA患者的48.4%、OA患者的17.6%,其中约55%总体报告使用OP药物。
  • OP care定义为接受OP治疗(钙剂/维生素D除外)或筛查(OPTS)。

临床怎么用

  • 对RA患者应主动评估OP治疗与筛查指征,尤其高龄、绝经后、既往脆性骨折或OP、使用糖皮质激素或生物制剂者。
  • 不应默认RA患者的OP管理优于OA患者,需按指南落实筛查与治疗。
  • 2010年ACR GIOP指南发布后OP care未见改善,提示需加强指南落地与质量改进。

局限性

  • 原文未报告研究局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To profile osteoporosis (OP) care in patients with rheumatoid arthritis (RA) over the past decade. METHODS: Patients with RA or osteoarthritis (OA) were followed from 2003 through 2014. OP care was defined as receipt of OP treatment (with the exception of calcium/vitamin D) or screening (OPTS). Adjusted trends over followup, and the factors associated with OP care, were examined using multivariable Cox proportional hazards. RESULTS: OPTS was reported in 67.4% of 11,669 RA patients and in 64.6% of 2,829 OA patients during a median (interquartile range) 5.5 (2-9) years of followup. In patients for whom treatment was recommended by the 2010 American College of Rheumatology (ACR) glucocorticoid-induced OP (GIOP) guidelines (48.4% of RA patients and 17.6% of OA patients), approximately 55% overall reported OP medication use. RA patients were not more likely to undergo OPTS compared to OA patients (hazard ratio 1.04 [95% confidence interval 0.94-1.15]). Adjusted models showed a stable trend for OPTS between 2004 and 2008 compared to 2003, with a significant downward trend after 2008 in both RA and OA patients. Factors associated with receipt of OP care in RA patients were older age, postmenopausal state, prior fragility fracture or diagnosis of OP, any duration of glucocorticoid treatment, and use of biologic agents. CONCLUSION: Approximately half of RA patients for whom treatment was indicated never received an OP medication. OP care in RA patients was not better than in OA patients, and the relative risk of the application of this care has been decreasing in RA and OA patients since 2008 without improvement after the release of the 2010 ACR GIOP guideline.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Ozen G, Kamen DL, Mikuls TR, et al. Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis. Arthritis Care Res (Hoboken). 2018. PMID: 28771973. doi:10.1002/acr.23331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。